Diet and Coronary Heart Disease: Clinical Trials

Overview

Journal Curr Atheroscler Rep

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2000 Dec 21

PMID 11122783

Citations 7

Authors

M E Brousseau

E J Schaefer

Affiliations

Soon will be listed here.

Abstract

Dietary intervention trials using coronary heart disease (CHD) mortality and morbidity as endpoints have demonstrated that restriction of dietary total and saturated fat or replacement of the latter with polyunsaturated fatty acids (PUFAs), in particular n-3 PUFAs, is of great benefit with respect to CHD risk. This is likewise the case for intervention trials using angiographic endpoints, with many studies showing that such diets not only retard progression of coronary atherosclerosis but can cause regression as well. The role that antioxidants, such as vitamin E, may play in the development and progression of CHD is less clear. The results of large-scale clinical trials evaluating the effect of vitamin E supplementation on CHD risk do not support the concept that this agent is cardioprotective. The purpose of this report is to review dietary intervention trials that support a direct relationship between diet, lipoproteins, and CHD risk.

Citing Articles

Influence of parental education levels on eating habits of pupils in Nigerian primary schools.

Umoke M, Umoke P, Onyeke N, Victor-Aigbodion V, Eseadi C, Ebizie E Medicine (Baltimore). 2020; 99(43):e22953.

PMID: 33120857 PMC: 7581186. DOI: 10.1097/MD.0000000000022953.

Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages.

Papackova Z, Palenickova E, Dankova H, Zdychova J, Skop V, Kazdova L Nutr Metab (Lond). 2012; 9:22.

PMID: 22439764 PMC: 3348013. DOI: 10.1186/1743-7075-9-22.

Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome.

Fessler M, Rudel L, Brown J Curr Opin Lipidol. 2009; 20(5):379-85.

PMID: 19625959 PMC: 3099529. DOI: 10.1097/MOL.0b013e32832fa5c4.

Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance.

Miller M, Beach V, Sorkin J, Mangano C, Dobmeier C, Novacic D J Am Diet Assoc. 2009; 109(4):713-7.

PMID: 19328268 PMC: 2693202. DOI: 10.1016/j.jada.2008.12.023.

Therapeutic lifestyle change and Adult Treatment Panel III: evidence then and now.

Stone N, Van Horn L Curr Atheroscler Rep. 2002; 4(6):433-43.

PMID: 12361490 DOI: 10.1007/s11883-002-0047-x.

References

Dreon D, Vranizan K, Krauss R, Austin M, Wood P . The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. JAMA. 1990; 263(18):2462-6. View

. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269(23):3015-23. View

. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study.... Can J Cardiol. 1996; 12(2):127-37. View

Lichtenstein A, Ausman L, Jalbert S, Schaefer E . Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med. 1999; 340(25):1933-40. DOI: 10.1056/NEJM199906243402501. View

Judd J, Clevidence B, Muesing R, Wittes J, Sunkin M, Podczasy J . Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr. 1994; 59(4):861-8. DOI: 10.1093/ajcn/59.4.861. View

JOLLIEFFE N, Baumgartner L, RINZLER S, Archer M, Stephenson J, CHRIST AKIS G . The Anti-Coronary Club. The first four years. N Y State J Med. 1963; 63:69-79. View

Miettinen M, Turpeinen O, KARVONEN M, ELOSUO R, Paavilainen E . Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet. 1972; 2(7782):835-8. DOI: 10.1016/s0140-6736(72)92208-8. View

Ornish D, Brown S, Scherwitz L, Billings J, Armstrong W, Ports T . Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990; 336(8708):129-33. DOI: 10.1016/0140-6736(90)91656-u. View

Zock P, Katan M . Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res. 1992; 33(3):399-410. View

10.

Haskell W, Alderman E, Fair J, Maron D, Mackey S, Superko H . Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994; 89(3):975-90. DOI: 10.1161/01.cir.89.3.975. View

11.

Mensink R, Katan M . Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990; 323(7):439-45. DOI: 10.1056/NEJM199008163230703. View

12.

de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J, Monjaud I . Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994; 343(8911):1454-9. DOI: 10.1016/s0140-6736(94)92580-1. View

13.

. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994; 330(15):1029-35. DOI: 10.1056/NEJM199404143301501. View

14.

Nelson A . Treatment of atherosclerosis by diet. I. Results in patients followed from 36 to 72 months. Northwest Med. 1956; 55(6):643-9. View

15.

Turpeinen O, ROINE P, PEKKARINEN M, KARVONEN M, RAUTANEN Y, RUNEBERG J . Effect on serum-cholesterol level of replacement of dietary milk fat by soybean oil. Lancet. 1960; 1(7117):196-8. DOI: 10.1016/s0140-6736(60)90112-4. View

16.

Spady D, Bilheimer D, Dietschy J . Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci U S A. 1983; 80(11):3499-503. PMC: 394072. DOI: 10.1073/pnas.80.11.3499. View

17.

MORRISON L . A nutritional program for prolongation of life in coronary atherosclerosis. J Am Med Assoc. 1955; 159(15):1425-8. DOI: 10.1001/jama.1955.02960320001001. View

18.

Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson M . Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996; 347(9004):781-6. DOI: 10.1016/s0140-6736(96)90866-1. View

19.

Lichtenstein A, Welty F, Li Z, Lamon-Fava S, Dolnikowski G, Schaefer E . Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. Arterioscler Thromb Vasc Biol. 1999; 19(4):918-24. DOI: 10.1161/01.atv.19.4.918. View

20.

DAYTON S, PEARCE M, Goldman H, Harnish A, Plotkin D, SHICKMAN M . Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet. 1968; 2(7577):1060-2. DOI: 10.1016/s0140-6736(68)91531-6. View